ConductScience.org, home

Paper8652248

Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer.

Berger CC and 4 others. Eur J Cancer, 1995. Cited by 79 papers, by iCite.

Cite this record

ConductScience Library. Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer. Papers, record 8652248. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8652248

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer.
PubMed
Journal
Eur J Cancer
PubMed
Year
1995
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
79
iCite
Relative citation ratio, by iCite
2.18
iCite
Revised in PubMed
2019-07-18
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Berger CCC C
2Bokemeyer CC
3Schneider MM
4Kuczyk MAM A
5Schmoll HJH J

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Raynaud DiseaseMajor topic
SeminomaMajor topic
Testicular NeoplasmsMajor topic
Vascular DiseasesMajor topic
Adult
Bleomycin
Blood Flow Velocity
Cisplatin
Etoposide
Fingers
Humans
Male
Middle Aged
Plethysmography
Risk Factors
Vinblastine

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00161174Cardiovascular Morbidity in Testicular Cancer Survivors: Study of Risk Factors and Assessment of Pharmacogenomic Determinants of ToxicityBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.

PMIDTitleJournalYearIn PapersSource
38249337Major adverse cardiovascular events in advanced-stage lung cancer: a multicenter cohort study.Ther Adv Med Oncol2024https://conductscience.org/library/papers/38249337PubMed
35905486Testicular cancer survivorship: Long-term toxicity and management.Can Urol Assoc J2022https://conductscience.org/library/papers/35905486PubMed
32631603Cancer and Scleroderma.Rheum Dis Clin North Am2020https://conductscience.org/library/papers/32631603PubMed
32190815Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management.JNCI Cancer Spectr2020https://conductscience.org/library/papers/32190815PubMed
29264402Mechanistic and clinical insights at the scleroderma-cancer interface.J Scleroderma Relat Disord2017https://conductscience.org/library/papers/29264402PubMed
27885347Fludarabine Treatment of Patient with Chronic Lymphocytic Leukemia Induces a Digital Ischemia.Case Rep Hematol2016https://conductscience.org/library/papers/27885347PubMed
27421216Cancer and autoimmunity: Harnessing longitudinal cohorts to probe the link.Best Pract Res Clin Rheumatol2016https://conductscience.org/library/papers/27421216PubMed
26949933Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers.Br J Clin Pharmacol2016https://conductscience.org/library/papers/26949933PubMed
26352736Cancer and scleroderma: a paraneoplastic disease with implications for malignancy screening.Curr Opin Rheumatol2015https://conductscience.org/library/papers/26352736PubMed
26347114Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors.Ann Oncol2015https://conductscience.org/library/papers/26347114PubMed
23345497Old drugs: new complications.BMJ Case Rep2013https://conductscience.org/library/papers/23345497PubMed
23273834Topical combinations aimed at treating microvascular dysfunction reduce allodynia in rat models of CRPS-I and neuropathic pain.J Pain2013https://conductscience.org/library/papers/23273834PubMed
22956534Chemotherapy-induced ovarian failure as a prototype for acute vascular toxicity.Oncologist2012https://conductscience.org/library/papers/22956534PubMed
21825998Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications.Curr Opin Rheumatol2011https://conductscience.org/library/papers/21825998PubMed
21505757Does cisplatin-based chemotherapy effect on blood lipid levels of patients with germ cell testicular tumor in long-term follow-up?Int Urol Nephrol2011https://conductscience.org/library/papers/21505757PubMed
20506513Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies.Arthritis Rheum2010https://conductscience.org/library/papers/20506513PubMed
19940282Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.J Natl Cancer Inst2009https://conductscience.org/library/papers/19940282PubMed
19517112Paraneoplastic Raynaud's phenomenon in a breast cancer survivor.Rheumatol Int2010https://conductscience.org/library/papers/19517112PubMed
17322957Extensive deep vein thrombosis as a complication of testicular cancer treated with the BEP protocol (bleomycin, etoposide and cisplatin): case report.Sao Paulo Med J2006https://conductscience.org/library/papers/17322957PubMed
16620142Advances in the treatment of testicular cancer.Drugs2006https://conductscience.org/library/papers/16620142PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8652248

GET https://conductscience.org/api/papers/v1/8652248/cited_by?page=2